| |
| |
|
| Insider
Information: |
Moore Alison |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
741,307 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$247,559 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
741,307 |
|
|
| Total
Value |
$247,559 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Allogene Therapeutics, Inc. |
ALLO |
|
2023-03-22 |
672,731 |
2019-06-03 |
0 |
Premium* |
|
|
Codexis Inc |
CDXS |
|
2023-06-13 |
68,576 |
2020-06-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
38 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
37,050 |
37,050 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-06-03 |
4 |
OE |
$2.27 |
$110,840 |
D/D |
48,828 |
86,385 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-06-03 |
4 |
AS |
$26.74 |
$1,306,774 |
D/D |
(48,828) |
37,557 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-06-28 |
4 |
OE |
$2.27 |
$63,142 |
D/D |
27,816 |
65,373 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-07-26 |
4 |
OE |
$2.27 |
$29,948 |
D/D |
13,193 |
78,566 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-07-26 |
4 |
AS |
$29.18 |
$384,994 |
D/D |
(13,193) |
65,373 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-07-29 |
4 |
AS |
$29.39 |
$699,870 |
D/D |
(23,815) |
65,373 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-07-29 |
4 |
OE |
$2.27 |
$54,060 |
D/D |
23,815 |
89,188 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-07-30 |
4 |
OE |
$2.27 |
$26,829 |
D/D |
11,819 |
77,192 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-07-30 |
4 |
AS |
$29.85 |
$352,738 |
D/D |
(11,819) |
65,373 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-09-16 |
4 |
AS |
$32.00 |
$168,234 |
D/D |
(5,257) |
66,067 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-09-16 |
4 |
OE |
$2.27 |
$11,933 |
D/D |
5,257 |
71,324 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-09-17 |
4 |
OE |
$2.27 |
$51,082 |
D/D |
22,503 |
88,570 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-09-17 |
4 |
AS |
$32.11 |
$722,560 |
D/D |
(22,503) |
66,067 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-09-18 |
4 |
OE |
$2.27 |
$47,822 |
D/D |
21,067 |
87,134 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2019-09-18 |
4 |
AS |
$32.13 |
$676,872 |
D/D |
(21,067) |
66,067 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2020-03-16 |
4 |
S |
$19.19 |
$71,980 |
D/D |
(3,750) |
63,021 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2020-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
30,800 |
93,821 |
0 |
- |
|
| CDXS |
Codexis Inc |
Director |
– • – |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
17,905 |
17,905 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2020-08-13 |
4 |
OE |
$2.27 |
$73,664 |
D/D |
32,451 |
126,272 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2020-10-06 |
4 |
OE |
$2.27 |
$80,049 |
D/D |
35,264 |
161,536 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2020-10-06 |
4 |
AS |
$40.00 |
$1,782,960 |
D/D |
(44,574) |
117,680 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2020-10-08 |
4 |
OE |
$2.27 |
$11,498 |
D/D |
5,065 |
122,745 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2020-10-08 |
4 |
AS |
$41.00 |
$207,665 |
D/D |
(5,065) |
117,680 |
0 |
- |
|
| ALLO |
Allogene Therapeutics, In... |
Chief Technical Officer |
• – – |
2020-10-09 |
4 |
OE |
$2.27 |
$68,552 |
D/D |
30,199 |
147,879 |
0 |
- |
|
38 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
